About Taiwan Cooperative Oncology Group, National Health Research Institutes
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Taiwan Cooperative Oncology Group, National Health Research Institutes
During the past decade, Taiwan Cooperative Oncology Group, National Health Research Institutes conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Taiwan Cooperative Oncology Group, National Health Research Institutes"
#1 collaborator was "National Cheng-Kung University Hospital" with 3 trials as a collaborator, "National Taiwan University Hospital" with 3 trials as a collaborator, "Chang Gung Memorial Hospital" with 2 trials as a collaborator, "Kaohsiung Medical University Chung-Ho Memorial Hospital" with 2 trials as a collaborator and "Taipei Veterans General Hospital, Taiwan" with 2 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Taiwan Cooperative Oncology Group, National Health Research Institutes
According to Clinical.Site data, the most researched conditions in "Taiwan Cooperative Oncology Group, National Health Research Institutes" are
"Advanced Biliary Tract Cancer" (1 trials), "Biliary Cancers" (1 trials), "Biliary Tract Neoplasms" (1 trials), "Esophageal Cancer" (1 trials) and "Gastric Cancer in Situ" (1 trials). Many other conditions were trialed in "Taiwan Cooperative Oncology Group, National Health Research Institutes" in a lesser frequency.
Clinical Trials Intervention Types at Taiwan Cooperative Oncology Group, National Health Research Institutes
Most popular intervention types in "Taiwan Cooperative Oncology Group, National Health Research Institutes" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Oxaliplatin" (2 trials), "Albumin-Bound Paclitaxel /nab-Paclitaxel" (1 trials), "Cisplatin" (1 trials), "Gemcitabine" (1 trials) and "LV" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Taiwan Cooperative Oncology Group, National Health Research Institutes
The vast majority of trials in "Taiwan Cooperative Oncology Group, National Health Research Institutes" are
4 trials for "All" genders.
Clinical Trials Status at Taiwan Cooperative Oncology Group, National Health Research Institutes
Currently, there are NaN active trials in "Taiwan Cooperative Oncology Group, National Health Research Institutes".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Taiwan Cooperative Oncology Group, National Health Research Institutes,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Taiwan Cooperative Oncology Group, National Health Research Institutes, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".